Chargepoint Technology
Private Company
Total funding raised: $11.2M
Overview
Chargepoint Technology is a specialized provider of engineering solutions for aseptic processing in the life sciences industry. Founded in 1993, the company has established itself as a leader in containment and transfer technology, crucial for the manufacture of sterile injectables, biologics, and potent compounds. Its products are integral to ensuring regulatory compliance, operator safety, and product protection in GMP environments. The company operates in a stable, niche market driven by stringent regulatory standards and the growth of complex biopharmaceuticals.
Technology Platform
Hardware and engineering platform for aseptic transfer and containment, featuring proprietary valve systems for sterile and safe material transfer in pharmaceutical manufacturing.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Chargepoint competes in a niche segment with specialized peers and large, diversified life science tools companies like Sartorius, Cytiva (formerly part of GE), and Merck Millipore. Competition is based on technical performance, reliability, regulatory support, and deep integration into customer processes rather than price alone.